Search research articles
Contact Us
Filters
Showing results (91-100 of 100) with videos related to
Page
of 10
Sort By:
You have reached the last page of results.
This site can display upto 100 results.
Analytical Biochemistry
|
April 1, 1986
Preparation of tyrosine-O-[35S]sulfated cholecystokinin octapeptide from a nonsulfated precursor peptide
T Nakahara, M Waki, H Uchimura, et al.
Biochimica Et Biophysica Acta
|
May 13, 1993
A comparative study of the solution structures of tachyplesin I and a novel anti-HIV synthetic peptide, T22 ([Tyr5,12, Lys7]-polyphemusin II), determined by nuclear magnetic resonance
H Tamamura, M Kuroda, M Masuda, et al.
The American Journal of Clinical Nutrition
|
January 11, 1992
Differences in skeletal muscle and bone mineral mass between black and white females and their relevance to estimates of body composition
O Ortiz, M Russell, T L Daley, et al.
ASAIO Journal (American Society for Artificial Internal Organs : 1992)
|
November 14, 1997
Comparative blood compatibility of polyether vs polycarbonate urethanes by epifluorescent video microscopy
D Mizumoto, C Nojiri, Y Inomata, et al.
Bioorganic & Medicinal Chemistry
|
May 23, 1998
Downsizing of an HIV-cell fusion inhibitor, T22 ([Tyr5,12, Lys7]-polyphemusin II), with the maintenance of anti-HIV activity and solution structure
H Tamamura, M Waki, M Imai, et al.
Bioorganic & Medicinal Chemistry
|
April 21, 1998
Effective lowly cytotoxic analogs of an HIV-cell fusion inhibitor, T22 ([Tyr5,12, Lys7]-polyphemusin II)
H Tamamura, R Arakaki, H Funakoshi, et al.
The Journal of Experimental Medicine
|
October 23, 1997
A small molecule CXCR4 inhibitor that blocks T cell line-tropic HIV-1 infection
T Murakami, T Nakajima, Y Koyanagi, et al.
Bioorganic & Medicinal Chemistry
|
September 8, 1998
Pharmacophore identification of a chemokine receptor (CXCR4) antagonist, T22 ([Tyr(5,12),Lys7]-polyphemusin II), which specifically blocks T cell-line-tropic HIV-1 infection
H Tamamura, M Imai, T Ishihara, et al.
Journal of Virology
|
August 10, 1999
Inhibitory mechanism of the CXCR4 antagonist T22 against human immunodeficiency virus type 1 infection
T Murakami, T Y Zhang, Y Koyanagi, et al.
Osaka City Medical Journal
|
June 1, 1997
A case of membranous glomerulonephritis associated with gastric cancer
M Waki, E Ishimura, H Morii, et al.
Page
of 10
Search research articles
Search
Showing results (91-100 of 100) with videos related to
Sort By:
Page
of 10
You have reached the last page of results.
This site can display upto 100 results.
Analytical Biochemistry
|
April 1, 1986
Preparation of tyrosine-O-[35S]sulfated cholecystokinin octapeptide from a nonsulfated precursor peptide
T Nakahara, M Waki, H Uchimura, et al.
Biochimica Et Biophysica Acta
|
May 13, 1993
A comparative study of the solution structures of tachyplesin I and a novel anti-HIV synthetic peptide, T22 ([Tyr5,12, Lys7]-polyphemusin II), determined by nuclear magnetic resonance
H Tamamura, M Kuroda, M Masuda, et al.
The American Journal of Clinical Nutrition
|
January 11, 1992
Differences in skeletal muscle and bone mineral mass between black and white females and their relevance to estimates of body composition
O Ortiz, M Russell, T L Daley, et al.
ASAIO Journal (American Society for Artificial Internal Organs : 1992)
|
November 14, 1997
Comparative blood compatibility of polyether vs polycarbonate urethanes by epifluorescent video microscopy
D Mizumoto, C Nojiri, Y Inomata, et al.
Bioorganic & Medicinal Chemistry
|
May 23, 1998
Downsizing of an HIV-cell fusion inhibitor, T22 ([Tyr5,12, Lys7]-polyphemusin II), with the maintenance of anti-HIV activity and solution structure
H Tamamura, M Waki, M Imai, et al.
Bioorganic & Medicinal Chemistry
|
April 21, 1998
Effective lowly cytotoxic analogs of an HIV-cell fusion inhibitor, T22 ([Tyr5,12, Lys7]-polyphemusin II)
H Tamamura, R Arakaki, H Funakoshi, et al.
The Journal of Experimental Medicine
|
October 23, 1997
A small molecule CXCR4 inhibitor that blocks T cell line-tropic HIV-1 infection
T Murakami, T Nakajima, Y Koyanagi, et al.
Bioorganic & Medicinal Chemistry
|
September 8, 1998
Pharmacophore identification of a chemokine receptor (CXCR4) antagonist, T22 ([Tyr(5,12),Lys7]-polyphemusin II), which specifically blocks T cell-line-tropic HIV-1 infection
H Tamamura, M Imai, T Ishihara, et al.
Journal of Virology
|
August 10, 1999
Inhibitory mechanism of the CXCR4 antagonist T22 against human immunodeficiency virus type 1 infection
T Murakami, T Y Zhang, Y Koyanagi, et al.
Osaka City Medical Journal
|
June 1, 1997
A case of membranous glomerulonephritis associated with gastric cancer
M Waki, E Ishimura, H Morii, et al.
Page
of 10